System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Ilesh Jani is an expert in Infectiology at Instituto Nacional de Saúde (Mozambique). Ilesh Jani has authored 163 publications, the most recent in 2026, and is an investigator in 13 clinical trials, 2 of them ongoing. SLR score: 686 (community average: 125). How the SLR is computed.

LeadR Profile

Ilesh Jani Instituto Nacional de Saúde Mozambique
686 ScienceLeadR Reputation 686

Unlock

Register Login
Network Map

Infectiology

Subspecialties: Public Health - Immunology - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1998 - 2026
Source: PubMed

Instituto Nacional de Saúde

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 163

Citations

Citations: 4 319 1st author: 13 Last author: 33 Unique author: 1

Main journals

PLoS One 24
Clin Infect Dis 13
J Int AIDS Soc 9
BMC Infect Dis 6
J Acquir Immune Defic Syndr 5

Best Journals

Lancet 2
N Engl J Med 2
Nat Med 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Timely and Efficient Infant Diagnosis Is Required to End AIDS in Children.
PMID 42319178 — research design, breast feeding, acquired immunodeficiency syndrome, diagnosis, therapeutics, child, infant		J Int AIDS Soc20261
Long-term cross-variant Fc-mediated immune responses against SARS-CoV-2 induced by a heterologous adenoviral/inactivated virus prime-boost vaccination strategy.
PMID 42168193 — sars-cov-2, vaccines, vaccination, viruses, immunity, severe acute respiratory syndrome-related coronavirus		NPJ Vaccines20260
Understanding trial designs and acceptability of participation in an HIV vaccine trial with concurrent randomisation to oral pre-exposure prophylaxis in East and Southern Africa: a longitudinal qualitative study.
PMID 42141483 — vaccines, pre-exposure prophylaxis, hiv		Trials20260
Point-of-care early infant HIV diagnosis at birth in a pragmatic cluster-randomized trial in Mozambique and Tanzania: A comparative cost and cost-effectiveness study.
PMID 42090430 — research design, parturition, point-of-care systems, infectious disease transmission, vertical, respect, hiv, diagnosis, infant		PLoS Med20260
The future of diagnostics in Africa.
PMID 42020602 — research design, disease outbreaks, molecular biology		Nat Med Top journal20260

Clinical Studies 13

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4

By phase:

N/A 6
Phase 2 4
Phase 1 1
Phase 1/Phase 2 1
Phase 2/Phase 3 1

By status:

Completed 10
Active not recruiting 1
Recruiting 1
Unknown 1

By type:

Interventional 10
Observational 3

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 6
multicentric5to9 3
multicentricup10 1

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Increasing Neonatal HIV Test and Treat to Maximize the Long Term Impact on Infant Health and Novel Infant Antiretroviral Treatment
NCT06267508 — research design, mothers, infant, newborn, risk assessment, communication, infant, newborn, diseases, viral load, solutions, acquired immunodeficiency syndrome, infant health, hiv, viruses, diagnosis, health facilities, morbidity, therapeutics, hiv infections, infant death, infections, infant		N/ARecruiting2024
Mix and Match Heterologous Prime Boost Study Using Approved COVID 19 Vaccines
NCT04998240 — cells, vero cells, sars-cov-2, myeloma proteins, safety, saline solution, vaccines, virion, covid-19 vaccines, adenoviridae, paraproteins, solutions, aged, covid-19, viruses, severe acute respiratory syndrome-related coronavirus, biological products		Phase 2Active not recruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS